(RTTNews) - AbbVie Inc. (ABBV) Thursday said that the U.S. Food and Drug Administration (FDA) has approved Vyalev for the treatment of motor fluctuations in adults with advanced Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback